Reassuring data from 539,478 individuals in the Copenhagen General Population Study, the Copenhagen City Heart Study, and the UK Biobank show that low Lp(a) level does not increase the risk of Alzheimer’s disease or vascular-related dementia (VRD).
Educational Partners and Supporters
(Founding Partner)
Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum.